In reptiles, over the last years the importance of diseases caused by fungal infections has steadily increased. Chamaeleomyces sp. is a relatively new, but more and more relevant pathogen causing systemic mycosis in chameleons. The aim of this study therefore was to obtain information on the occurrence of these fungi in chameleons, to describe their clinical appearance and to evaluate potential diagnostic procedures. 41 chameleons belonging to six different species, and demonstrating clinical signs suspicious for a Chamaeleomyces infection, were clinically examined. Samples were obtained and examined cytologically, bacteriologically, mycologically as well as with molecular methods. Ten animals additionally underwent a pathological examination. The clinical findings included proliferations on the tongue, the throat and the skin, petechial bleedings, joint swellings as well as inflammatory alterations of the eye. In 13 animals the fungi could be detected cytologically. Mycological cultivation was successful in 16 animals. Molecular-biological methods revealed Chamaeleomyces granulomatis in 13 veiled chameleons and Chamaeleomyces viridis in three panther chameleons and one carpet chameleon. Notably, pathogen detection was not equally successful from samples taken from the different areas with clinical alterations. The results of this study demonstrate that, even though the clinical signs of the infection are variable, specific findings such as granulomatous alterations on the tongue and throat occur particularly often. The study also shows that the verification by PCR is the most reliable method. However mycological and repeated cytological examinations are also advisable. In case of doubt, several diagnostic procedures should be combined.
Download full-text PDF |
Source |
---|
JAMA Netw Open
January 2025
Medical Oncology, The Ottawa Hospital Cancer Centre, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada.
Importance: Evolving breast cancer treatments have led to improved outcomes but carry a substantial financial burden. The association of treatment costs with the cost-effectiveness of screening mammography is unknown.
Objective: To determine the cost-effectiveness of population-based breast cancer screening in the context of current treatment standards.
J Acquir Immune Defic Syndr
January 2025
Emory University Rollins School of Public Health, Department of Behavioral, Social, and Health Education Sciences.
Background: Pre-exposure prophylaxis for HIV prevention (PrEP) prescriptions in the U.S. have increased, yet only 15% of individuals assigned female at birth who could benefit from PrEP had received prescriptions as of 2022, with marked racial disparities.
View Article and Find Full Text PDFJ Acquir Immune Defic Syndr
January 2025
Centre for Infectious Disease Epidemiology and Research, School of Public Health, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Background: Data on tuberculosis (TB) incidence and risk factors among children living with HIV (CLHIV) in the universal ART era are limited.
Methods: We analysed routinely-collected data on TB diagnoses for CLHIV age ≤5 years, born 2018-2022, in the Westen Cape, South Africa. We examined factors associated with TB diagnosis, with death and loss to follow-up as competing events.
Invest Ophthalmol Vis Sci
January 2025
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China.
Purpose: To investigate the 10-year changes in visual function and incidence of visual impairment (VI) in highly myopic eyes.
Methods: This longitudinal study enrolled highly myopic individuals who were followed up for 10 years. All participants underwent detailed ophthalmic examinations at baseline and follow-up visits.
Invest Ophthalmol Vis Sci
January 2025
Southern California College of Optometry at Marshall B Ketchum University, Fullerton, California, United States.
Purpose: When treating amblyopia, it is important to define when visual acuity (VA) is no longer improving (i.e., stable) because treatment decisions may be altered based on this determination.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!